Bipolar disorder (BD) is a recurrent illness associated with serious consequences in the psychosocial functioning of the child and increased risk for legal problems, suicidality, and substance abuse. Often it can take several years until the diagnosis of BD in youth is made, which in part is due to difficulties recognizing its existence and the overlap of its symptoms with other disorders. With each recurrence, the prognosis of BD worsens indicating the early identification and treatment of BD in youth. The goal of this presentation is to present the difficulties and differential diagnosis of pediatric BD and the course and factors associated with its the course.
Recording is for delegates only.
Infographic
Bipolar disorder (BD) is a recurrent illness associated with serious consequences in the psychosocial functioning of the child and increased risk for legal problems, suicidality, and substance abuse. Often it can take several years until the diagnosis of BD in youth is made, which in part is due to difficulties recognizing its existence and the overlap of its symptoms with other disorders. With each recurrence, the prognosis of BD worsens indicating the early identification and treatment of BD in youth. The goal of this presentation is to present the difficulties and differential diagnosis of pediatric BD and the course and factors associated with its the course.
Learning outcomes
1. Identify the difficulties and importance of correctly diagnosing bipolar disorder (BD) in youth.
2. Discuss the differential diagnosis of BD.
3. Review how the course of illness and family history may inform the diagnosis of BD
About the speaker
Dr. Boris Birmaher is the Endowed Chair in Bipolar Disease and Distinguished Professor of Psychiatry at the University of Pittsburgh, School of Medicine. He received his medical degree from in Colombia SA; completed training in general psychiatry in Jerusalem, Israel, and child psychiatry at Columbia University, New York.
Dr. Birmaher is a leader in the study and treatment of pediatric mood and anxiety disorders. His research has concentrated in describing the predictors, risk factors, course, and treatment of mood and anxiety disorders. He has served as Principal, Co-Principal / co-investigator for over 25 federally sponsored research grants and authored/co-authored over 500 publications, book chapters as well as his own book, New Hope for Children and Teens with Bipolar Disorder.
He has been the recipient of numerous awards including the Colvin Prize for Outstanding Achievement in Mood Disorders Research from the Brain and Behavior Research Foundation (2013), the Ittleson Award for Research in Child and Adolescent Psychiatry (2014), the Gerald L Klerman Senior Investigator Award (2018), The Lifelong Fellow Award from the American Psychiatric Association (2018), The Leadership in Child, Adolescent and Young Adult Psychiatry Award from the American College of Psychiatrists (2022), the Ruane Prize from the Brain and Behavior Research Foundation (2022) and the C. Charles Burlingame Award from the Institute of Living, Hartford Healthcare (2022).
For four years and until 10/2018 he was the Program Chair of the American Academy of Child and Adolescent Psychiatry and recently was named Counselor-At-Large of the same association.
Through his research, clinical and mentoring activities, Dr. Birmaher has increased our understanding of the risk factors for mood and anxiety disorders, developed and implemented innovative treatments to improve the lives of patients and their families, and trained the next generation of educators, clinicians, and researchers.